
Novartis Scraps Non-Compete Payment to Departing Chairman
Become a member: Subscribe
Solari’s Building Wealth materials are organized to inspire and support your personal strategic and financial planning.

Missing Money
Articles and video discussions of the $21 Trillion dollars missing from the U.S. government
No posts
Novartis Scraps Non-Compete Payment to Departing Chairman
 
		By Julia Werdigier
Novartis, one of Switzerland’s biggest drug makers, said Tuesday it scrapped a planned $78 million payment to its departing chairman because of pressure from shareholders and lawmakers.
Novartis said it cancelled an agreement with Daniel Vasella to pay him 72 million Swiss francs over the next six years to keep him from sharing his knowledge with competitors. The decision comes three days before the company’s board is to face investors at the annual shareholder meeting.
Our mission is to help you live a free and inspired life. This includes building wealth in ways that build real wealth in the wider economy. We believe that personal and family wealth is a critical ingredient of both individual freedom and community, health and well-being.
Nothing on The Solari Report should be taken as individual investment, legal, or medical advice. Anyone seeking investment, legal, medical, or other professional advice for his or her personal situation is advised to seek out a qualified advisor or advisors and provide as much information as possible to the advisor in order that such advisor can take into account all relevant circumstances, objectives, and risks before rendering an opinion as to the appropriate strategy.
Be the first to know about new articles, series and events.
 
				
































































































